Emergent BioSolutions makes naloxone overdose treatments and medical countermeasures against threats like anthrax and smallpox. It last closed at $5.62 on Nov 17, down 3.19% on the day.
Only 1 firm rated EBS in the past 90 days, not enough for a consensus
Average 12-month target
$16.00
▲ 184.7% upside
Based on 1 analyst who set a price target on EBS in the past 90 days. The average target is $16.00, with a high of $16.00 and a low of $16.00, compared with the last close of $5.62.
Low $16.00Avg $16.00High $16.00
Blue marker: last close $5.62
Highest target$16.00
Average target$16.00
Lowest target$16.00
Latest rating changes
Rodman & RenshawInitiated
Sep 25Buy$16
HC Wainwright & Co.Maintained
Aug 10Buy$10
Date
Firm
Action
Rating
Price target
Sep 25
Rodman & Renshaw
Initiated
Buy
$16
Aug 10
HC Wainwright & Co.
Maintained
Buy
$10
Loading…
Technical Analysis
EBS · as of the Nov 17 close · updated after every close
Downtrend, nearing oversold
The stock is 11% below its 20 day and 15% below its 50 day average. It is 37% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 36), near oversold. The nearest support is the swing low (Sep 10) at $5.50, and the nearest resistance the Pivot at $5.69.
Short trendBearish
Long trendBearish
MomentumWeak
StretchNear oversold
VolatilityHigh, 6.8%/day
Key levels
$14.0652 week high+150.2%
$7.68200 day average+36.7%
$6.60Swing high (Sep 3)+17.4%
$6.57100 day average+16.9%
$6.4950 day average+15.5%
$6.2320 day average+10.9%
$5.83Pivot R1+3.7%
$5.69Pivot+1.2%
$5.62Last close
$5.50Swing low (Sep 10)−2.1%
$5.47Pivot S1−2.7%
$4.3652 week low−22.4%
Indicators
RSI (14)
35.76
Weak, oversold below 30
Neutral
MACD
-0.22
Below its signal line
Bearish
Stochastic
25.4
Middle of its range
Neutral
ADX (14)
25.2
Trending down
Williams %R
-80.1
Oversold below −80, overbought above −20
Oversold
CCI (20)
-117.1
Oversold below −100, overbought above 100
Oversold
Rate of change
−10.1%
Change over 10 sessions
Bearish
ATR (14)
$0.38
Typical daily range, 6.8% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Falling
Short trendBearish
Long trendNot enough history
MomentumNeutral
StretchNormal
VolatilityNormal, 17.1%/day
Key levels
$14.0652 week high+150.2%
$7.68200 day average+36.7%
$6.60Swing high (Sep 3)+17.4%
$6.57100 day average+16.9%
$6.4950 day average+15.5%
$6.2320 day average+10.9%
$5.83Pivot R1+3.7%
$5.69Pivot+1.2%
$5.62Last close
$5.50Swing low (Sep 10)−2.1%
$5.47Pivot S1−2.7%
$4.3652 week low−22.4%
Indicators
RSI (14)
40.40
Middle of its range
Neutral
MACD
-0.55
Above its signal line
Bullish
Stochastic
43.5
Middle of its range
Neutral
ADX (14)
13.2
No clear trend
Williams %R
-63.0
Oversold below −80, overbought above −20
Neutral
CCI (20)
-69.6
Oversold below −100, overbought above 100
Neutral
Rate of change
−9.8%
Change over 10 sessions
Bearish
ATR (14)
$0.96
Typical daily range, 17.1% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200–
What happened before, for EBS
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how EBS did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
November seasonalityHow EBS usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How EBS has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2006.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether EBS is in one of them and how their past EBS trades turned out.
Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.
About Emergent BioSolutions
Emergent BioSolutions is a life sciences company based in Gaithersburg, Maryland, that develops and sells products for preparing for and responding to public health threats. Its main products are NARCAN nasal spray and KLOXXADO, which reverse opioid overdoses and are sold through pharmacies, health departments and community groups. It also supplies vaccines, antitoxins and antibiotics for threats such as anthrax and smallpox, mainly to government agencies, with the U.S. government as its largest customer. The company also offers contract manufacturing services to drug developers.